Clinical Application of New Advances in the Treatment of Head and Neck Cancer

Watch this brief expert video to review the current standard of care for your patients with advanced metastatic head and neck cancer.

Barbara Burtness, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 11, 2020 Expired: No longer available for credit

Watch this brief expert video to review the optimal use of immune checkpoint inhibitors in the frontline setting in patients with advanced metastatic head and neck cancer.

Barbara Burtness, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 10, 2020 Expired: No longer available for credit

Watch this brief expert video to review the future potential of immune checkpoint inhibitors in patients with head and neck cancer.

Barbara Burtness, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 18, 2020 Expired: No longer available for credit

Watch this brief video with an expert to learn why testing for NTRK fusions in patients with head and neck cancer is recommended.

Aarti Bhatia, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 21, 2020 Expired: No longer available for credit

Watch this brief expert video to learn recommended strategies for testing for NTRK fusions in patients with head and neck cancer.

Aarti Bhatia, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 21, 2020 Expired: No longer available for credit

Watch this brief expert video to learn recommended treatment strategies for patients with head and neck cancer and NTRK fusions.

Aarti Bhatia, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 22, 2020 Expired: No longer available for credit

Watch this brief expert video to learn recommended management strategies for patients with head and neck cancer experiencing immune-related adverse events.

Elisabeth King, RN, FNP, AGN, AOCNP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 8, 2021 Expired: No longer available for credit

Watch this brief expert video on molecular testing for patients with head and neck cancer.

Elisabeth King, RN, FNP, AGN, AOCNP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 18, 2021 Expired: No longer available for credit

Watch this brief expert video on the role of the immune system and immune escape in patients with head and neck cancer.

Dan P. Zandberg, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 22, 2021 Expired: No longer available for credit

Watch this brief expert video on the latest information on biomarkers for immunotherapy in patients with head and neck cancer.

Dan P. Zandberg, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 22, 2021 Expired: No longer available for credit